Blog
RSS FeedPosted by Michael Wonder on 19 Sep 2018
NICE rejects Novartis’ CAR-T Kymriah for adult lymphoma
19 September 2018 - The National Institute for Health and Care Excellence has turned down NHS funding for use of ...
Posted by Michael Wonder on 19 Sep 2018
NICE encourages further discussions on Kymriah for adult lymphoma
19 September 2018 - CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft ...
Posted by Michael Wonder on 18 Sep 2018
Information forums - streamlining PBS medicines listing processes
18 September 2018 - The Department of Health in collaboration with Medicines Australia will be hosting information forums in both ...
Posted by Michael Wonder on 18 Sep 2018
Changes to TGA/PBAC parallel processing arrangements for biosimilar medicines
18 September 2018 - Submissions requesting the listing of a new biosimilar medicine are no longer eligible to be submitted under ...
Posted by Michael Wonder on 17 Sep 2018
Pharma companies avoid estimated $215m a year in local tax: Oxfam
18 September 2018 - Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in ...
Posted by Michael Wonder on 17 Sep 2018
Targeted treatment for melanoma to be free on NHS
17 Septembre 2018 - Hundreds of patients with a type of aggressive skin cancer will be offered a targeted therapy ...
Posted by Michael Wonder on 17 Sep 2018
Patients with high-risk skin cancer have new treatment option
17 September 2018 - Hundreds of patients with a type of advanced skin cancer are set to benefit from a new ...
Posted by Michael Wonder on 14 Sep 2018
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...
Posted by Michael Wonder on 14 Sep 2018
Blood cancer drugs added to PBS
14 September 2018 - The Federal Government is spending $48 million to provide more affordable drugs for Australians with blood ...
Posted by Michael Wonder on 13 Sep 2018
PHARMAC defends position not to fund bowel cancer drug
14 September 2018 - PHARMAC is defending its position to not fund a drug recommended to patients with late-stage bowel cancer ...
Posted by Michael Wonder on 13 Sep 2018
Dying cancer patients refused PHARMAC funding
13 September 2018 - Dying patients who suffer a rare reaction to chemotherapy are having to pay for their own ...
Posted by Michael Wonder on 13 Sep 2018
DoH moves to ensure equal access to cancer drugs in Northern Ireland
13 September 2018 - The Department of Health in Northern Ireland has unveiled plans to boost access to innovative new ...
Posted by Michael Wonder on 12 Sep 2018
A breakthrough cancer drug has been approved. Now comes the battle over the price.
12 Septemner 2018 - Novartis' breakthrough cancer drug Kymriah has been approved in Europe. Now comes the debate about its ...
Posted by Michael Wonder on 12 Sep 2018
Battle for wonder drug pays off
13 September 2018 - A West Pymble mother feels the “weight of the world” has been lifted following the federal ...
Posted by Michael Wonder on 12 Sep 2018
In Australia, NovaTears eye drops are available on the Pharmaceutical Benefits Scheme
12 September 2018 - Using innovative new technology, NovaTears effectively establishes a new class of treatment for evaporative dry eye. ...